Second, although relevant concomitant diseases affecting SAA level were mentioned in the exclusion criteria, we were not able to exclude patients with atherosclerosis and related cardiovascular disease, one of the most frequent concomitant inflammatory diseases in COPD [27,28,29] because, as mentioned earlier, this was a real-life study. This evidence concerns the gene SAA1 and chronic obstructive pulmonary disease.